Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that it has entered ...

Roku's balance sheet holds no debt, and more than 20% of its market cap is made up of cash. Check out why I find myself cautiously neutral on ROKU stock.

LATAM Airlines is executing well, with double-digit operating margins and a strong path to deleveraging. Learn why LTM stock ...